MeSH term
Frequency | Condition_Probility | Acute Disease | 2 | 0.0 |
Adult | 7 | 0.0 |
Bone Marrow Transplantation/*statistics & numerical data | 2 | 2.0 |
Comparative Study | 14 | 0.0 |
Cord Blood Stem Cell Transplantation/*statistics & numerical data | 2 | 2.0 |
Fetal Blood/transplantation | 2 | 2.0 |
Humans | 110 | 0.0 |
Leukemia/*therapy | 2 | 1.0 |
Patient Selection | 2 | 1.0 |
Animals | 60 | 0.0 |
Adolescent | 3 | 0.0 |
Female | 18 | 0.0 |
Male | 8 | 0.0 |
Middle Aged | 3 | 0.0 |
Time Factors | 5 | 0.0 |
Adjuvants, Immunologic/*pharmacology | 7 | 4.0 |
Cell Line | 21 | 0.0 |
*CpG Islands | 4 | 5.0 |
DNA-Binding Proteins/*metabolism | 6 | 0.0 |
*Drosophila Proteins | 19 | 1.0 |
Membrane Glycoproteins/*metabolism | 5 | 1.0 |
Mice | 41 | 0.0 |
Oligodeoxyribonucleotides/*pharmacology | 10 | 32.0 |
Receptors, Cell Surface/*metabolism | 11 | 1.0 |
Research Support, Non-U.S. Gov't | 59 | 0.0 |
Signal Transduction | 16 | 0.0 |
Antigens, Differentiation/physiology | 2 | 3.0 |
Chloroquine/pharmacology | 3 | 3.0 |
NF-kappa B/physiology | 3 | 3.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
TNF Receptor-Associated Factor 6 | 4 | 3.0 |
Up-Regulation/immunology | 3 | 1.0 |
Cell Division/immunology | 4 | 1.0 |
Cells, Cultured | 25 | 0.0 |
CpG Islands/*immunology | 6 | 37.0 |
Cytokines/biosynthesis | 8 | 1.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
Dose-Response Relationship, Immunologic | 3 | 0.0 |
Interphase/immunology | 2 | 4.0 |
Lymphocyte Activation/*immunology | 2 | 0.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Base Sequence | 9 | 0.0 |
DNA-Binding Proteins/*immunology | 2 | 8.0 |
Dendritic Cells/immunology | 6 | 4.0 |
Interleukin-6/immunology | 2 | 7.0 |
Mice, Inbred BALB C | 8 | 0.0 |
NF-kappa B/immunology | 3 | 16.0 |
Oligodeoxyribonucleotides/immunology | 4 | 66.0 |
Receptors, Cell Surface/*immunology | 6 | 7.0 |
Spleen/immunology | 2 | 1.0 |
Cell Differentiation | 6 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Lymphocyte Activation | 4 | 0.0 |
Membrane Glycoproteins/metabolism | 4 | 0.0 |
Mice, Knockout | 9 | 0.0 |
NF-kappa B/metabolism | 7 | 0.0 |
Receptors, Cell Surface/metabolism | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
*Signal Transduction | 5 | 0.0 |
CpG Islands/*genetics | 2 | 2.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Antigens, Differentiation/metabolism | 4 | 3.0 |
Protein Kinases/metabolism | 2 | 0.0 |
Receptors, Immunologic/metabolism | 2 | 1.0 |
Species Specificity | 4 | 0.0 |
Bacterial Infections/immunology | 2 | 8.0 |
CpG Islands/*physiology | 2 | 18.0 |
Gene Expression | 3 | 0.0 |
Ligands | 10 | 0.0 |
Signal Transduction/genetics | 2 | 0.0 |
DNA-Binding Proteins/*physiology | 3 | 0.0 |
Interferon-alpha/*biosynthesis | 3 | 17.0 |
Membrane Glycoproteins/*physiology | 7 | 2.0 |
Mice, Inbred C57BL | 16 | 0.0 |
Receptors, Cell Surface/*physiology | 8 | 3.0 |
Antigens, CD8/*analysis | 2 | 2.0 |
Dendritic Cells/*physiology | 5 | 6.0 |
Membrane Glycoproteins/physiology | 3 | 1.0 |
Receptors, Cell Surface/physiology | 4 | 3.0 |
Up-Regulation | 2 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
DNA Primers | 3 | 0.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Aged | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
*Immunity, Natural | 4 | 6.0 |
Lipopolysaccharides/immunology | 4 | 3.0 |
Molecular Sequence Data | 9 | 0.0 |
Signal Transduction/*immunology | 3 | 0.0 |
Antibodies/immunology | 2 | 0.0 |
Dose-Response Relationship, Drug | 6 | 0.0 |
Membrane Glycoproteins/*genetics | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Receptors, Cell Surface/*genetics | 4 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Drug Synergism | 4 | 0.0 |
Interleukin-12/*biosynthesis | 2 | 5.0 |
Th1 Cells/immunology | 2 | 1.0 |
English Abstract | 2 | 0.0 |
*Receptors, Immunologic | 4 | 2.0 |
CpG Islands | 4 | 1.0 |
Lipopolysaccharides/pharmacology | 8 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
eIF-2 Kinase/physiology | 2 | 22.0 |
Immunity, Cellular | 2 | 0.0 |
Membrane Glycoproteins/genetics/*metabolism | 7 | 4.0 |
Models, Biological | 4 | 0.0 |
Receptors, Cell Surface/genetics/*metabolism | 6 | 4.0 |
Macrophages/metabolism | 3 | 0.0 |
Signal Transduction/*physiology | 3 | 0.0 |
DNA, Bacterial/immunology | 2 | 50.0 |
Macrophages/immunology | 3 | 1.0 |
Signal Transduction/immunology | 4 | 1.0 |
Dendritic Cells/cytology/*immunology/metabolism | 2 | 15.0 |
Mice, Inbred C3H | 3 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Trans-Activation (Genetics)/*immunology | 2 | 10.0 |
Transfection | 8 | 0.0 |
T-Lymphocytes, Helper-Inducer/immunology | 2 | 1.0 |
Adjuvants, Immunologic/pharmacology | 2 | 2.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Membrane Glycoproteins/*immunology | 6 | 3.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
DNA-Binding Proteins/metabolism/*physiology | 2 | 1.0 |
Down-Regulation/immunology | 3 | 3.0 |
Receptors, Cell Surface/metabolism/*physiology | 2 | 10.0 |
Signal Transduction/drug effects/immunology | 2 | 4.0 |
Th1 Cells/drug effects/immunology | 4 | 40.0 |
Flagellin/pharmacology | 2 | 28.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
NF-kappa B/*metabolism | 2 | 0.0 |
Oligodeoxyribonucleotides/pharmacology | 2 | 8.0 |
Phosphorylation | 2 | 0.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 4 | 0.0 |
Receptors, Cell Surface/*analysis | 2 | 1.0 |
Immunity, Natural/immunology | 2 | 8.0 |
Dendritic Cells/*immunology | 2 | 0.0 |
Immunoglobulin M/biosynthesis | 2 | 2.0 |
Immunologic Memory | 3 | 1.0 |
In Vitro | 2 | 0.0 |
Interferon-alpha/biosynthesis | 3 | 12.0 |
Cell Movement/immunology | 2 | 2.0 |
Coculture Techniques | 2 | 0.0 |
DNA-Binding Proteins/deficiency/genetics/*physiology | 2 | 8.0 |
Signal Transduction/genetics/*immunology | 3 | 3.0 |
Body Mass Index | 2 | 0.0 |
CpG Islands/immunology | 8 | 61.0 |
Swine | 2 | 0.0 |
Apoptosis/immunology | 2 | 2.0 |
Cell Degranulation/immunology | 2 | 13.0 |
Cell Differentiation/immunology | 3 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Protein Binding | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
*Virus Replication | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Membrane Glycoproteins/immunology | 4 | 2.0 |
Receptors, Cell Surface/immunology | 2 | 5.0 |
Adjuvants, Immunologic/*pharmacology/therapeutic use | 2 | 14.0 |
Leukocytes, Mononuclear/drug effects/immunology | 2 | 4.0 |
Case-Control Studies | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
DNA Methylation | 2 | 0.0 |
DNA-Binding Proteins/genetics/*immunology | 2 | 14.0 |
Membrane Glycoproteins/genetics/*immunology | 2 | 3.0 |
Receptors, Cell Surface/genetics/*immunology | 3 | 13.0 |
*Chromosome Mapping | 3 | 0.0 |
*Genetic Predisposition to Disease | 3 | 0.0 |
Genetics, Population | 3 | 0.0 |
Genome, Human | 3 | 0.0 |
Antigens, CD14/biosynthesis | 2 | 3.0 |
Lymphocyte Activation/immunology | 2 | 0.0 |
CD40 Ligand/*physiology | 2 | 33.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Membrane Glycoproteins/*biosynthesis/genetics | 2 | 3.0 |
Oligodeoxyribonucleotides/*immunology | 3 | 33.0 |
DNA, Bacterial/*immunology | 2 | 40.0 |
Ultraviolet Rays | 2 | 0.0 |
Lipopolysaccharides/metabolism/pharmacology | 2 | 11.0 |
Oligodeoxyribonucleotides/metabolism/pharmacology | 2 | 100.0 |
Poly I-C/metabolism/pharmacology | 2 | 100.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Superoxides/metabolism | 2 | 0.0 |
Up-Regulation/genetics/immunology | 2 | 3.0 |
Immunity, Natural | 3 | 1.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Recombinant Fusion Proteins/physiology | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Models, Immunological | 2 | 0.0 |
*Immunity | 2 | 4.0 |
Dendritic Cells/*immunology/physiology | 2 | 18.0 |
